相关实验视频
Updated: Sep 17, 2025

07:23
Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
6.2K
RAB7通过促进非正规的TUFM线粒细胞衰竭途径,防止缺血性心力衰竭
Yuling Sun1, Wei Wang2, Mingyan Li3
1Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, China.
Theranostics
|June 30, 2025
概括
细胞废物清除的关键调节者RAB7,通过清除受损的线粒体来保护心脏. 激活RAB7可能为缺血性心力衰竭提供一种新疗法.
科学领域:
- 心脏病学 心脏病学
- 细胞生物学 细胞生物学
- 分子医学是分子医学.
背景情况:
- 心肌细胞亡是缺血性心力衰竭 (IHF) 的关键驱动因素.
- 内体-溶解体系统调节细胞平衡,但RAB7在心脏病中的作用尚不清楚.
研究的目的:
- 研究RAB7在心脏病理生理学中的作用,特别是在缺血性心力衰竭的背景下.
- 探索RAB7在调节心肌细胞存活和线粒细胞衰变中的机制.
主要方法:
- 利用心肌细胞特异性RAB7淘汰和过度表达的肌动脉梗塞 (MI) 的小鼠模型.
- 通过心声学和病理学分析评估心脏功能和重塑.
- 使用IP-MS和验证实验量化了线粒细胞流和阐明了分子机制.
主要成果:
- 在缺血性心脏组织中,RAB7的表达减少.
- 拉布7缺乏症恶化,而拉布7过度表达改善了后心脏病的结果.
- 通过招募TUFM和LC3到受损的线粒体,RAB7增强了线粒体,减少了心肌细胞亡.
- 一种RAB7激活剂 (ML-098) 缓解了小鼠的IHF进展.
结论:
- RAB7是一种通过TUFM介导途径的心脏保护性线粒细胞衰变的新型调节剂.
- RAB7-TUFM轴是治疗缺血性心力衰竭的潜在治疗点.
相关概念视频
The Unfolded Protein Response
5.1K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
5.1K
Regulation of the Unfolded Protein Response
2.6K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
Regulated Protein Degradation
2.6K
2.6K
MAPK Signaling Cascades
6.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.2K

